Although there was no statistical significance for UC, a strong trend in the incidence of leukopenia was observed during immunosuppressive agent use compared with placebo in patients with UC (7/113 vs. 0/106, respectively) (Figure S1).
← all excerpts
Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis.
1
—
—